QQ
微信
| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| OregovoMab | OregovoMab | 213327-37-8 |
| Gemtuzumab | 吉妥珠单抗奥唑米星 | 220578-59-6 |
| Eculizumab | 托西珠单抗 | 219685-50-4 |
| Euphorbia factor L8 | 大戟因子L8 | 218916-53-1 |
| euphorbiafactor L2 | 千金子素L2 | 218916-51-9 |
| 6-ROX, SE | 6-羧基-X-罗丹明琥珀酰亚胺酯 | 216699-36-4 |
| FLUORESCEIN DIPHOSPHATE, TETRAAMMONIUM SALT | 1, 6-二磷酸果糖钠 | 217305-49-2 |
| 5-ROX, SE | 5-羧基-X-罗丹明 SE | 209734-74-7 |
| Alemtuzumab | 阿伦单抗 | 216503-57-0 |
| bexxar | bexxar | 208921-02-2 |
| EFALIZUMABUM | EFALIZUMABUM | 214745-43-4 |
| Vobarilizumab | Vobarilizumab | 1628814-88-9 |
| N-benzylpentadecanamide | N-苄基十五碳酰胺 | 1572037-13-8 |
| Cy5 DBCO | Cy5 DBCO | 1564286-24-3 |
| Satralizumab Linker | Satralizumab Linker | 1491917-83-9 |
| N-(3-methoxybenzyl)-octadecanamide | N-(3-甲氧基苄基)-十八碳酰胺 | 1429659-99-3 |
| Durvalumab | 德瓦鲁单抗 | 1428935-60-7 |
| bimekizumab | BIMEKIZUMAB | 1418205-77-2 |
| BID | 人BH3结构域凋亡诱导蛋白(BID)ELISA试剂盒 | 1416258-16-6 |
| Lambrolizumab | 派姆单抗 | 1374853-91-4 |
